SC 13G

Company

Eledon Pharmaceuticals, Inc.

Filed

November 5, 2024

Accession Number

0001193125-24-251059

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →